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Background: Severe falciparum malaria (SM) remains a major cause of death in tropical countries. The reduced
activity of ADAMTS13, increasing levels of ultra-large von Willebrand factor (ULVWF) in SM patients, are assumed
as factors that intensify disease severity. However, the reason why ADAMTS13 activity is reduced in SM remains
unclear.
Objectives: To investigate whether rs4962153, febrile temperature, and microparticles, contribute to reduced
ADAMTS13 activity.
Methods: Genotypic association of rs4962153 with ADAMTS13 antigen and activity was examined in 362 healthy
Thai participants. The collagen binding assay was used to study the effects of febrile temperature and
microparticles on ADAMTS13 activity.
Results: ADAMTS13 antigen and activity were decreased in participants with AA genotype, compared to AG and
GG (antigen: p-value = 0.014, and < 0.001; activity: p-value = 0.036, and < 0.002, respectively). There was significantly
reduced ADAMTS13 antigen in AG compared to GG (p-value = 0.013), but not in ADAMTS13 activity (p-value = 0.082).
The number of rs4962153 A alleles correlated with the reduced level of antigen and activity (p-value <0.001 and
p-value = 0.001, respectively). MPs showed an inhibitory effect on ADAMTS13 activity (p-value = 0.025). Finally,
ADAMTS13 activity was decreased in a temperature and time-dependent manner. The interaction between these
two factors was also observed (p-value <0.001).
Conclusions: These findings suggest that the A allele of rs4962153, MPs, and febrile temperature, contribute to reduce
ADAMTS13 activity in plasma. These data are useful in malaria or other diseases with reduced ADAMTS13 activity.
Keywords: ADAMTS13, Cell-derived microparticles, Fever, Plasmodium falciparum, Malaria, Single nucleotide polymorphismBackground
Plasmodium falciparum malaria is a life-threatening dis-
ease in tropical countries, which causes approximately 500
million clinical cases, resulting in about 650,000 deaths
each year [1]. Cerebral malaria (CM) is the most serious
complication of severe malaria (SM) contributing to cause
of death. Central pathophysiology of CM is the sequestra-
tion of parasitized red blood cells (PRBCs) in the cerebral
microvasculature, which leads to microvascular obstruction
and endothelial activation, including the release of von* Correspondence: nantadao@gmail.com
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reproduction in any medium, provided the orWillebrand factor (vWF) from its storage site in the endo-
thelium, Weibel-Palade bodies [2]. However, the pathogen-
esis of CM remains poorly understood.
vWF is a large multimeric plasma glycoprotein that
plays an important role in primary haemostasis by me-
diating the adhesion of platelets to sites of vascular in-
jury. Normally, vWF and platelet-decorated vWF string is
cleaved and regulated by an endogenous protease, a disin-
tegrin and metalloproteinase with a thrombospondin type
1 motif, member 13 (ADAMTS13). Interestingly, the level
of vWF and its propeptide are increased in SM patients
compared to uncomplicated malaria and healthy control,
and the increased level related with disease severity [3].
Moreover, there was abnormal ULVWF, a highly activeLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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aggregation to the vessel wall, in SM and CM patients ra-
ther than normal control [4,5]. These data correspond with
the reduced activity of ADAMTS13 in SM and CM pa-
tients [4,6]. Furthermore, most symptoms of CM including
fever, renal failure, microangiopathic haemolytic anaemia,
neurological deficits and thrombocytopaenia, are com-
monly found in thrombotic thrombocytopaenic purpura
(TTP), a rare life-threatening disease, which is caused by a
congenital or acquired deficiency of ADAMTS13. Conse-
quently, the factors causing the reduction of ADAMTS13
antigen and activity are, therefore, important in the patho-
genesis of SM and CM.
It is well known that mutations in ADAMTS13 gene
contribute congenital TTP. A relatively large number of
mutations and polymorphisms have been identified in
ADAMTS13 [7]. Recent study reported that the A allele
of an intronic SNP, rs4962153, is associated with de-
creased risk of CM [8]. However, the effect of this SNP
to expression level and activity of ADAMTS13 have not
been studied.
A number of studies reported that level of MPs is in-
creased in plasma with SM and CM, and correlated with
disease severity [9-11]. MPs are vesicular particles released
from blood cells, from which their functionalities are
dependent on their original cell types. Surprisingly,MPs
enhance the function of vWF during vascular injury, caus-
ing formation and more stability of platelet aggregation
[12]. Although, some studies suggested that MPs derived
from endothelial cells and platelets seem to have inhibitory
capacity on ADAMTS13 activity [13,14], those are very
preliminary studies. Activity of ADAMTS13 in plasma is
quite stable. No significant decrease in ADAMTS13 activ-
ity is observed during storage at room temperature for up
to 48 hr and 37°C for longer than one week; however,
whether febrile temperature has any effect on ADAMTS13
activity has not been reported [15,16]. As fever is one of
the symptoms established in both of TTP and SM, sug-
gesting that effects of febrile temperature to ADAMTS13
activity should be investigated.
The aim of the present study was, therefore, to examine
the effects from interesting factors that were found in SM
on ADAMTS13. Genotypic association between rs4962153
and ADAMTS13 was explored in the Thai population.
In addition, ADAMTS13 activity was measured in MPs-
enriched plasma compared to MPs-depleted plasma. Fi-
nally, the activity of ADAMTS13 was determined in
febrile-like plasma samples compared to normal plasma.
Methods
Subjects
A total of 362 healthy Thai people aged 18–44 years
old were recruited in this study (254 females and
108 males). Those participants were healthy withoutfever, inflammation, infection, and taking of any anti-
inflammatory medicines for at least seven days before
blood collection. Furthermore, the participants had no
medical history of any coagulopathies including haemo-
philia, thromboembolism, bleeding disorders, heart dis-
eases, and severe inflammatory diseases. This study has
approved by the Ethics Review Committee for Research
Involving Human Research Subjects, Health Science
Group, Chulalongkorn University, Thailand. Written in-
formed consent was obtained from all participants.
DNA extraction
Genomic DNA was extracted from EDTA blood using a
FavorPrep™ FABGK genomic DNA Extraction mini kit
according to the manufacturer’s instruction (Favorgen,
Australia).
Genotyping
rs4962153 (g.41635A >G), a significant SNP of ADAMTS13
gene associated with cerebral malaria [8], was genotyped
by TaqMan SNP Genotyping Assay for 362 healthy par-
ticipants using StepOnePlus™ Real-Time PCR systems
(Applied Biosystems, USA).
Genotypic association study
34 of 362 participants were selected by convenience sam-
pling and classified by their genotypes into three groups,
which are GG, AG, or AA (19, 13 and two samples, re-
spectively). Citrated plasma samples were collected from
those participants and then the level of ADAMTS13 anti-
gen and activity were performed using commercial kits
(Quantikine Human ADAMTS13 ELISA kit; R&D Sys-
tems Inc., U.S.A, and Technozyme ADAMTS13 activity
ELISA; Technoclone, Austria). The level of ADAMTS13
antigen and activity in each sample was determined in
duplicate.
Effect of microparticles on ADAMTS13 activity
Nineteen participants with genotype GG of rs496215.
Three who presented the range of ADAMTS13 activity
from 80 to 90% were enrolled in this study. The plasma
samples were first prepared from platelet rich plasma
(PRP), which was carefully collected after centrifugation at
250 g for 15 min at room temperature. The PRP was then
centrifuged at 13,000 g for 3 min at room temperature.
The MPs-enriched plasma was taken, which is referred to
as ‘Non-filtered (NF)’ plasma throughout this article. The
residual plasma was exhaustively filtered using Mimisart®
Syringe filter hydrophilic with a pore size of 0.2 μm
(Sartorius Stedim Biotech, Germany) to deplete MPs. The
MPs-depleted plasma will be indicated throughout this
article as ‘Filtered (F)’ plasma. Flow cytometry was used to
confirm the events of MPs in both of NF and F plasma
samples as described previously [11]. The ADAMTS13
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(CBA) as described below.
Effect of febrile temperature on ADAMTS13 activity
The same citrated plasma samples from 30 participants as
recruited in MPs test were used in this study. The aliquot
samples were separately incubated at three different tem-
peratures which are 37°C, 38°C and 39°C for 0, 3, 6, 12, 24
and 48 hr in each temperature. The ADAMTS13 activity
was measured by the CBA.
Measurement of ADAMTS13 activity by the collagen
binding assay
To measure the effects of febrile temperature and MPs,
the ADAMTS13 activity was analyzed in 30 citrated
plasma samples by CBA, as described with slight mo-
difications [17]. Importantly, febrile plasma samples
which were previously incubated at 38°C and 39°C in
plasma preparation process would be incubated at 38°C
and 39°C instead of 37°C in digestion step, respectively.
The chromogenic reaction in the final process was per-
formed by addition of 100 μl of substrate o-phenylene-
diamine dihydrochloride (5 mg) (Med OPD P6912,
Sigma Aldrich, USA). The ELISA reaction was stopped
by addition of 100 μl H2SO4 (3%) and absorbance
was read at 492 nm with reference length at 620 nm
using Sunrise™ absorbance reader (Tecan Group Ltd.
Switzerland). The ADAMTS13 activity in each sample
was determined in duplicate.
Normal pooled plasma (NPP), which was collected
from 30 healthy participants was used to generate a cali-
bration curve. The NPP was diluted in to 7 dilutions,
1:5, 1:10, 1:20, 1:40, 1:80, 1:160 and 1:320 in 1.5 M urea,
5 mM Tris, pH 8.0. The ADAMTS13 activity was read
from the sigmoid-like calibration curve using point-to-
point plot. The NPP dilution of 1:10 was defined as
107% of ADAMTS13 activity.
Statistical analyses
Data are presented as means ± SEMs and analyzed by
the software SPSS version 17.0 (SPSS Inc.). Statistical
significances in genotypic association and effect of fe-
brile condition were assessed by One-way ANOVA and
Two-way ANOVA with repeated measures, respectively.
A correction for multiple comparisons between individ-
ual groups was made using Tukey-HSD Post-Hoc ana-
lysis. Effect of MPs on ADAMTS13 was assessed using
the paired t-test. Linear regression was used to describe
the correlation between number of A allele of rs4962153
and ADAMTS13 antigen as well as activity as previously
described [18]. Briefly, genotypes of all participants were
coded as GG = 0, AG = 1, and AA = 2, according to the
number of A allele. The p-value of less than 0.05 was
considered to be of statistical significance.Results
Frequency of rs4962153 SNP in Thai population
Among the 362 healthy Thai people, the frequencies of
rs4962153 of ADAMTS13 gene were 337 (93.10%) of
genotype GG, 23 (6.35%) of genotype AG, and 2 (0.55%)
of genotype AA. The minor allele frequency of this SNP
was 3.98%, whereas heterozygote frequency was 6.35%.
Genotypic association study
ADAMTS13 antigens were remarkably decreased in partici-
pants with the AA genotypes of rs4962153 (mean ± SEM=
327.26 ± 62.53 ng/ml), compared to AG and GG genotypes
(mean ± SEM= 568.02 ± 32.54 ng/ml, p-value = 0.014, and
mean ± SEM= 683.91 ± 22.43 ng/ml, p-value < 0.001, re-
spectively). Similarly, the participants with AA genotype
represent the significant reduction of ADAMTS13 activ-
ity (mean ± SEM= 58.26 ± 5.83%), compared to the indi-
viduals with AG (mean ± SEM= 84.78 ± 3.5%, p-value =
0.036), and GG genotypes (mean ± SEM= 95.53 ± 3.25%,
p-value = 0.002). It should be noted that the comparison of
ADAMTS13 antigen between individuals with GG and AG
was significantly different, whilst no significant difference
of ADAMTS13 activity was observed between those indi-
viduals (p-value = 0.013 and 0.082, respectively; Figure 1).
Effect of microparticles on ADAMTS13 activity
The median (range) of MPs was significantly higher in
NF plasma (2,546 (1198–3,432/μl)) than F plasma (5 (2-
10/μl), p-value < 0.01). Interestingly, ADAMTS13 activity
in NF plasma was significantly decreased (mean ± SEM=
86.06 ± 6.94%), when compared to F plasma (mean ±
SEM= 104.03 ± 10.78%, p-value = 0.025; Figure 2). These
data could support the inhibitory role of MPs on
ADAMTS13 activity in plasma.
Effect of febrile temperature on ADAMTS13 activity
To investigate the effects from febrile temperatures, in-
cubation times, including the interaction effect between
temperatures and incubation time on ADAMTS13 activ-
ity, we used ANOVA with repeated measures (Table 1).
ADAMTS13 activities were different for the 6 incuba-
tions times (p-value < 0.001). The significant differences
in ADAMTS13 activity observed in plasma samples, in-
cubated at 37°C, 38°C and 39°C (p-value < 0.001), indi-
cate that temperature influences ADAMTS13 activity.
Moreover, incubation time and temperature also showed
the significant interaction effect on ADAMTS13 activ-
ity (p-value < 0.001). This effect means that the level of
ADAMTS13 activities at different temperatures was differ-
ent after incubation for 0 hr, 3 hr, 6 hr, 12 hr, 24 hr, and
48 hr. Indeed, following incubation at 37°C, 38°C and 39°C,
clear reductions in ADAMTS13 activity were observed in
a time-dependent manner (Figure 3). Following 6 hr of in-
cubation at 37°C, there was no significant reduction in
Figure 1 Genotypic association of rs4962153 genotype and
ADAMTS13 antigen and activity. (A) The mean of ADAMTS13
antigen levels in participants with AA, AG and GG genotype of
rs4962153 were 683.91, 568.02 and 327.26 ng/ml, respectively.
ADAMTS13 antigen levels in participants with AA genotype were
significantly reduced compared to both of AG and GG genotype
(P < 0.05 and < 0.001, respectively). Furthermore, ADAMTS13 antigen
in participants with AG genotype was also significantly decreased
when compared to GG genotype (P < 0.05). (B) ADAMTS13 activity
levels in participants with AA genotype (mean = 58.26%), were
significantly reduced when compared to AG genotype (mean =
84.78%; P < 0.05) and GG genotype (mean = 95.53%; P < 0.001).
The middle line referred mean of each individual genotype.
*P < 0.05, **P < 0.01, ***P < 0.001.
Figure 2 Inhibitory effect of MPs on ADAMTS13 activity.
Non-filtered plasma samples presented ADAMTS13 activity 86.06%,
which was significant lower than the filtered-plasma samples
(mean = 104.03%). *P < 0.05.
Table 1 Effects of Febrile temperatures and Incubation
time to ADAMTS13 activity*
Factors df F p-value
Incubation time 5 40.086 <0.001
Temperature 2 138.35 <0.001
Incubation time * Temperature 10 8.063 <0.001
*Incubation time *temperature = interaction effect of temperature and
incubation time; df = degree of freedom; F = F-test score.
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ever, after continuous incubation, the level of ADAMTS13
activity was significantly decreased at 12 hr, 24 hr, and
48 hr (Figure 3A). It should be noted that ADAMTS13 ac-
tivity in normal plasma was reduced by approximately
50% after incubation at 37°C for 48 hr. Similarly, the
ADAMTS13 activity was initially declined after incubation
at 38°C for 3 hr, compared to 0 hr. More significant reduc-
tion corresponded with increased incubation time; the
level of ADAMTS13 activity following incubation for48 hr at 38°C was decreased compared to 0 hr, by approxi-
mately 30%. These data might indicate that ADAMTS13
activity is more stable in 38°C than 37°C after incubation
for 48 hr (Figure 3B). Moreover, the incubation at 39°C
represented the strongest reduction of ADAMTS13 activ-
ity, as the inhibitory effect was initially observed in plasma
samples that were not incubated in preparation process
(0 hr). The inhibitory effect remains after incubation for
3 hr to 48 hr in a time-dependent manner. Interestingly,
ADAMTS13 was almost absent after the incubation for
48 hr under 39°C (mean ± SEM= 2.01 ± 1.01%; Figure 3C).
These data led us to assume that the level of ADAMTS13
activity in plasma samples without incubation in the prep-
aration process (0 hr) was declined by approximately 30%
and 60% after incubated at 38°C and 39°C during the
digesting process in CBA, respectively, compared to the
same plasma incubated under normal conditions (37°C).
Clear evidence of the temperature-dependent inhibitory
effect was observed (Figure 3D). ADAMTS13 activities
were most inhibited at 39°C, and the least inhibitory effect
observed at 37°C, with moderate inhibition at 38°C. To
confirm these events, Post-Hoc analysis was used to assess
the differences of ADAMTS13 activity at all temperatures,
37°C versus 38°C, 37°C versus 39°C, and 38°C versus 39°C,
in each incubation time. The result showed that there were
Figure 3 ADAMTS13 activity was reduced in the incubation time and temperature-dependent manners. (A, B &C) Clear evidence of a
time-dependent inhitition was observed either at 37°C, 38°C, or 39°C. *P < 0.05, **P < 0.01, ***P < 0.001. (D) A temperature-dependent inhibition
was observed. ADAMTS13 activity was significantly decreased at 38°C and 39°C incubation temperature, compared to 37°C for each incubation
time except for 24 hr of 38°C compared to 37°C (NS = Not significant). All results represent mean ± SEM.
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ities in most comparisons at each incubation time except
the comparison between 37°C and 38°C at 24 hr (p-value =
0.187; Table 2).
Discussion
A number of previous studies have shown that the level of
ULVWF and vWF multimers are higher in patients withTable 2 Level of ADAMTS13 activity in plasma incubated in n
Incubation
time (hr.)
% ADAMTS13 activity (mean ± SEM*)
37°C 38°C 39°C
0 87.75 ± 7.39 51.73 ± 2.57 20.36 ± 2.4
3 76.57 ± 4.89 42.67 ± 2.45 12.36 ± 1.7
6 70.87 ± 3.11 41.08 ± 1.09 8.80 ± 1.6
12 60.38 ± 5.19 34.24 ± 1.60 6.14 ± 1.4
24 44.65 ± 8.65 31.04 ± 1.03 3.60 ± 1.6
48 32.22 ± 3.49 23.83 ± 1.17 2.01 ± 1.0
*SEM = Standard Error of the Mean.SM and CM, together with decreased antigen and activity
of ADAMTS13, compared to healthy controls [4,6]. The
present finding revealed that AA genotype of rs4962153
associated with notably reduced activity and antigen of
ADAMTS13 in healthy participants, when compared to
AG and GG genotypes. The number of A allele showed
strong association with reduced ADAMTS13 antigen and
activity, which could confirm allele A is significant.ormal and febrile temperature
p-value (Post-Hoc Tukey HSD)
37°C vs 38°C 37°C vs 39°C 38°C vs 39°C
9 < 0.001 < 0.001 0.001
3 < 0.001 < 0.001 < 0.001
4 < 0.001 < 0.001 < 0.001
9 < 0.001 < 0.001 < 0.001
2 0.187 < 0.001 0.007
1 0.048 < 0.001 < 0.001
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tivity in normal plasma. Finally, febrile temperature and
incubation time themselves and interaction together sig-
nificantly decreased ADAMTS13 activity in temperature
and time-dependent manner.
In recent years genetic variation in ADAMTS13 gene as-
sociated with congenital TTP has been reported [7]. Inter-
estingly, a previous study has shown that an intronic SNP,
rs4962153-A, was significantly associated with protection
against CM in Thai patients [8]. This study was designed
to investigate the genotype and allele frequency in 362
healthy Thai participants. Considering genotype frequency,
AA genotype was rarely found in those participants. Cor-
respond with minor allele frequency (A allele), which was
less than 5% in this study. HapMap project revealed
that this SNP is unusually found in Asian population,
including Chinese, and Japanese (5.8%, and 9.9%, respect-
ively), whereas, commonly found in European and sub-
Saharan African (15.6% and 38.5%, respectively) [19]. In
this recent study, it was found that AA genotype associ-
ated with reduced ADAMTS13 antigen and activity com-
pared to AG and GG genotypes (Figure 1). Moreover, the
significant difference of ADAMTS13 antigen was also no-
ticed in a comparison between AG and GG genotype, but
not in ADAMTS13 activity. Although only two partici-
pants with AA genotype were enrolled in this study, the
individuals with GG genotypes had about two times higher
in both ADAMTS13 antigen and activity (2.09 and 1.64,
respectively). Furthermore, the level of antigen in partici-
pants with AA genotype (327.26 ± 62.53 ng/ml) was
slightly lower than the minimal level of normal range for
ADAMTS13 in citrate plasma (370–1403 ng/ml; Quanti-
kine® ELISA human ADAMTS13 manual), the activity in
those participants (58.26 ± 5.83%) was included in refer-
ence range (40–130%; TECHNOZYM® ADAMTS-13 Ac-
tivity manual). These data may explain that even if the
antigen level is low, there are some compensatory mecha-
nisms that can support normal ADAMTS13 activity. How-
ever, a study in a larger Thai population or in other
populations should be examined.
The A allele of rs4962153 was assumed to be a risk allele
as it associated with the decreased ADAMTS13 antigen
and activity in this present study. This finding supports a
Swedish study, which reported that rs4962153-A was asso-
ciated with susceptibility to ischemic stroke (IS) [20].
Therefore, rs4962153-A may reduce the ADAMTS13 ac-
tivity in IS patients. On the other hand, the A allele was
associated with decreased risk of CM in the previous study
[8]. As the transcription level of ADAMTS13 involved with
rs4962153-A is unlikely increased or decreased depending
on the situation, the reported associations may be false
positive in either study. However, this present study exam-
ined in healthy participants in vitro, functional factors
found in malaria patients may cause the difference. Toassess the results, the effect of this SNP on mRNA and/or
ADAMTS13 antigen as well as its activity in malaria pa-
tients should be further investigated. The information
about rs4962153 is not much investigated. It is an intronic
SNP without known function. This SNP is possibly in
strong linkage disequilibrium (LD) with a variant that reg-
ulates gene expression, or with a non-synonymous coding
SNP. Moreover, alternative splice site spanning the loca-
tion of rs4962153, including effect an enhancer/silencer
encoded within the intron, should be considered.
Platelets and ECs are activated, and then apoptosis is in-
creased in CM, which leads to MPs release in those cells.
MPs are submicronic membranous rudiments character-
ized by the elevated exposure on the external membrane
leaflet of anionic phospholipids, such as phosphatidylserine
(PS), carrying on their surface proteins from the original
cell types, which give them specific biological properties
[21]. Platelets are able to modulate PRBC cytoadherence
and PMPs represent the majority of circulating MPs. PMPs
transfer platelet antigens such as PECAM-1 and CD36,
which are major receptors supporting PRBC adhesion
[10,22]. An initial process of thrombus formation via vWF-
platelet interaction is the binding of platelet receptor
GPIbα to the vWF A1 domain, resulting in the exposure
of the binding and cleavage site for ADAMTS13 under
shear stress [10]. The present study has found an inhibi-
tory effect from MPs (mostly released from platelets) on
ADAMTS13 activity. This finding agrees with a prelimin-
ary study, which implied that activated platelets and PMPs
could regulate ADAMTS13 activity [14]. Altogether, the
increased PMPs in circulation could possibly compete in
binding ADAMTS13 by reducing and/or blocking its inter-
action with vWF, leading to conformational change and
less multimeric cleavage. It seems unlikely PMPs alone
strongly decrease ADAMTS13 activity as the activity in
PMPs-enriched plasma remained in normal range; how-
ever, high level of PMPs together with other risk possibly
contribute sturdily decrease ADAMTS13 activity and then
increase risk of thrombosis.
The present data show that following incubation at 37°C
for 48 hr, ADAMTS13 activity was slowly decreased, rep-
resent half-life about 24–48 hr in-vitro. The half-life is
slightly shorter than the respective half-live (48–72 hr) ob-
served in TTP patients [23]. This data is slightly in conflict
with an in-vitro study which reported that ADAMTS13
was quite stable with half-life longer than 1 week [16].
Since the studies have been examined in different popula-
tions and under different conditions, further independent
studies are needed to examine whether the findings can be
confirmed. ADAMTS13 activity was reduced continuously
during incubation with half-life spanning about 48 hr and
3 hr after incubation at 38°C and 39°C, respectively. More-
over the protease activity was markedly inactivated when
the temperature was increased (Figure 3). It seems likely
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and temperature. In falciparum malaria, core temperature
of patients may rise as high as 42°C. An in-vitro study re-
vealed that fever accelerates and increases the cytoadher-
ence of PRBCs to the major parasitized receptors, CD36
and ICAM-1 [24]. The possible mechanism may be related
with the inactivated ADAMTS13 activitiy, which results
insufficiently regulated the platelet-decorated ULVWF
strings.
These findings show that ADAMTS13 activity is reduced
in healthy Thai participants with AA genotype compared
to AG and GG genotype, and seems related to a number
of A alleles. Moreover, MPs and febrile temperature have
the capacity to inhibit and/or inactivate ADAMTS13. The
present findings are not implied only in malaria infection,
but also in other diseases for example, TTP, heart disease,
coagulopathies, and other inflammatory diseases.
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